Xiaobo Zhu

2.7k citations
108 papers · 2.0k indexed · h-index 27

Xiaobo Zhu

105 papers receiving 1.9k citations

Peers

Xiaobo Zhu
Comparison fields: 5 of 127
  • Rheumatology 309
  • Cancer Research 281
  • Molecular Biology 928
  • Biological Psychiatry 30
  • Nephrology 83
Replace Ke Xu with:
Ke Xu China
Wenjing Xu China
Xiaohua Wu China
Kailiang Zhou China
Angela D’Ascola Italy
Ximei Wu China
Qian Wu China
Xiaobo Zhu relative to Ke Xu China Ke Xu's profile →
Citations per field
00.5×3.1×
Ke Xu · 1×
Citations per year

Countries citing papers authored by Xiaobo Zhu

Since Specialization
Citations

This map shows the geographic impact of Xiaobo Zhu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaobo Zhu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaobo Zhu more than expected).

Fields of papers citing papers by Xiaobo Zhu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaobo Zhu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaobo Zhu. The network helps show where Xiaobo Zhu may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Xiaobo Zhu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Xiaobo Zhu Line = papers co-authored together Xiaobo Zhu links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20241
2 20242
3 202426
4 20249
5 20242
6 202311
7 20239
8 202212
9 20216
10 20201
11 20199
12 201839
13 201827
14
Diagnostic value of the pachymetry parameters measured by RTVueOCT for keratoconus
20172
15 20132
16 20139
17
Upregulation of heparanase in high-glucose-treated endothelial cells promotes endothelial cell migration and proliferation and correlates with Akt and extracellular-signal-regulated kinase phosphorylation.
201223
18 201133
19 201055
20 201060

About Xiaobo Zhu

Xiaobo Zhu is a scholar working on Neurology, Rheumatology and Biological Psychiatry, having authored 108 papers that have together received 2.0k indexed citations. Recurring topics across this work include Neurosurgical Procedures and Complications (13 papers), Osteoarthritis Treatment and Mechanisms (11 papers), Cerebrospinal fluid and hydrocephalus (8 papers), Traumatic Brain Injury and Neurovascular Disturbances (7 papers), Cancer-related molecular mechanisms research (6 papers), Advanced Biosensing Techniques and Applications (6 papers), Plant Stress Responses and Tolerance (5 papers) and Inflammasome and immune disorders (5 papers). The work is most often cited by research in Rheumatology (309 citations), Cancer Research (281 citations) and Molecular Biology (928 citations). Xiaobo Zhu has collaborated with scholars based in China, Hong Kong and United States. Frequent co-authors include Qing Jiang, Wangsen Cao, Fang Chen, Patrick Shu‐Hang Yung, Wei Ai, Yangzi Jiang, Ke Lu, Rocky S. Tuan, Kun Hou and Shanying Huang. Their work appears in journals such as Biomaterials, Biochemical and Biophysical Research Communications and The Plant Journal.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026